Anti–platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin

Categorical Data Analysis

1991 • 9,374 citations

Analysis of Binary Data

2008 • 2,760 citations

Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin

1995 • 2,330 citations

Heparin and Low-Molecular-Weight Heparin

1998 • 1,032 citations

Heparin and Low-Molecular-Weight Heparin

2004 • 948 citations

Subcutaneous Fondaparinux versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary Embolism

2003 • 885 citations

Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention

2004 • 826 citations

Fondaparinux vs Enoxaparin for the Prevention of Venous Thromboembolism in Major Orthopedic Surgery<subtitle>A Meta-analysis of 4 Randomized Double-blind Studies</subtitle>

2002 • 735 citations

Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee Surgery

2001 • 629 citations

Fondaparinux or Enoxaparin for the Initial Treatment of Symptomatic Deep Venous Thrombosis

2004 • 602 citations

Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial

2002 • 535 citations

An Improved Definition of Immune Heparin-Induced Thrombocytopenia in Postoperative Orthopedic Patients

2003 • 323 citations

Antibodies to Platelet Factor 4–Heparin After Cardiopulmonary Bypass in Patients Anticoagulated With Unfractionated Heparin or a Low-Molecular-Weight Heparin

1999 • 304 citations

Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia

2004 • 275 citations

Heparin-induced thrombocytopenia

2003 • 221 citations

Heparin-Associated Thrombocytopenia: The Antibody Is Not Heparin Specific

1992 • 221 citations

Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin

2004 • 213 citations

The Pharmacokinetics of Fondaparinux Sodium in Healthy Volunteers

2002 • 197 citations

Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia.

1992 • 190 citations

Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393

1996 • 182 citations

Characterization of the Structural Requirements for a Carbohydrate Based Anticoagulant with a Reduced Risk of Inducing the Immunological Type of Heparin-associated Thrombocytopenia

1995 • 161 citations

The epitope specificity of heparin‐induced thrombocytopenia

1996 • 156 citations

A NON-PARAMETRIC TEST FOR INTERVAL-CENSORED FAILURE TIME DATA WITH APPLICATION TO AIDS STUDIES

1996 • 149 citations

Incidence and clinical relevance of heparin‐induced antibodies in patients with deep vein thrombosis treated with unfractionated or low‐molecular‐weight heparin

2002 • 134 citations

Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis

2001 • 132 citations

Mode of interaction between platelet factor 4 and heparin

1993 • 128 citations

Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody

2002 • 123 citations

Heparin-induced Thrombocytopenia: IgG Binding to PF4-Heparin Complexes in the Fluid Phase and Cross-reactivity with Low Molecular Weight Heparin and Heparinoid

1998 • 110 citations

Antibodies From Patients With Heparin-Induced Thrombocytopenia/Thrombosis Recognize Different Epitopes on Heparin: Platelet Factor 4

1998 • 106 citations

Determination of heparin–platelet factor 4–IgG antibodies improves diagnosis of heparin‐induced thrombocytopenia

2001 • 100 citations

Successful treatment of heparin induced thrombocytopenia (HIT) with fondaparinux

2005 • 100 citations

Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia

2005 • 99 citations

Heparin‐induced thrombocytopenia and thrombosis

2005 • 83 citations

The Effect of the Synthetic Pentasaccharide SR 90107/ORG 31540 on Thrombin Generation Ex Vivo Is Uniquely due to ATIII-Mediated Neutralization of Factor Xa

1995 • 77 citations

Heparin‐associated thrombocytopenia in a patient treated with polysulphated chondroitin sulphate: evidence for immunological crossreactivity between heparin and polysulphated glycosaminoglycan

1992 • 76 citations

Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia

2002 • 66 citations

Antihirudin antibodies following low-dose subcutaneous treatment with desirudin for thrombosis prophylaxis after hip-replacement surgery: incidence and clinical relevance

2003 • 65 citations

Fondaparinux (ARIXTRA) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins.

2003 • 64 citations

Generalizations of current status data with applications

1995 • 51 citations

Pentosan‐induced thrombocytopenia: support for an immune complex mechanism

1994 • 35 citations

Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies

2002 • 35 citations

Aberrant expression of the major sialoglycoprotein (CD43) on the monocytes of patients with myelodysplastic syndromes

2000 • 26 citations

Role of Sulfated Polysaccharides in the Pathogenesis of Heparin- Induced Thrombocytopenia

2003 • 16 citations